SOLMUX PAEDIATRIC SUSPENSION 200 mg/5 ml
Product details
Registration number: SIN12251P
Classification: Pharmacy Only
Active ingredients: CARBOCISTEINE
Strength: 200 mg/5 ml
Dosage form: SUSPENSION
Route: ORAL
Registrant: GOLDPLUS UNIVERSAL PTE LTD
ATC code: R05CB03
HSA approval date: 3 April 2003
Manufacturer(s): Amherst Laboratories, Inc
Manufacturing country/countries: PHILIPPINES
What are the HSA registration number and classification for SOLMUX PAEDIATRIC SUSPENSION 200 mg/5 ml?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN12251P
Classification: Pharmacy Only
What active ingredients and strength are recorded for SOLMUX PAEDIATRIC SUSPENSION 200 mg/5 ml?
According to the HSA dataset updated 7 August 2026:
Active ingredients: CARBOCISTEINE
Strength: 200 mg/5 ml
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for SOLMUX PAEDIATRIC SUSPENSION 200 mg/5 ml?
According to the HSA dataset updated 7 August 2026:
Dosage form: SUSPENSION
Route: ORAL
Who is the recorded registrant for SOLMUX PAEDIATRIC SUSPENSION 200 mg/5 ml?
According to the HSA dataset updated 7 August 2026:
Registrant: GOLDPLUS UNIVERSAL PTE LTD
Which manufacturers and countries are listed for SOLMUX PAEDIATRIC SUSPENSION 200 mg/5 ml?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): Amherst Laboratories, Inc
Manufacturing country/countries: PHILIPPINES
Where can I look up SOLMUX PAEDIATRIC SUSPENSION 200 mg/5 ml in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN12251P or the exact product name SOLMUX PAEDIATRIC SUSPENSION 200 mg/5 ml. The general register link does not preselect this product.
What are the source dates for this SOLMUX PAEDIATRIC SUSPENSION 200 mg/5 ml record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this SOLMUX PAEDIATRIC SUSPENSION 200 mg/5 ml record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN12251P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)